ASCO GI 2021 | Disparities in access to screening and variation of targets in different groups

Afsaneh Barzi, MD, PhD, City of Hope Comprehensive Cancer Center, Duarte, CA, discusses disparities in access to screening and variation of targets in different groups as evaluated in the targeted therapies, emerging targets, and next-generation sequencing for gastrointestinal cancers general session in the annual American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium. Dr Barzi highlights the underrepresentation of minorities in clinical trials that ultimately hinders access to appropriate and effective treatment approaches. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).